Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-019071)

Filing Details

Accession Number:: 0001209191-14-019071
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-11 06:06:34
Reporting Period:: 2014-03-06

Filing Date:: 2014-03-11
Accepted Time:: 2014-03-11 06:06:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087432	Intermune Inc	ITMN	Pharmaceutical Preparations (2834)	943296648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1469029	A Jonathan Leff	3280 Bayshore Boulevard Brisbane CA 94005	Evp Of R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-06	748	$31.75	45,879	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares sold in this transaction were acquired pursuant to a restricted stock award granted in June of 2012. The number of shares sold were only that which was necessary to cover the taxes owed upon the vesting of such restricted stock award.